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Objective: The objective of this study was to investigate whether epicardial cryoabla-
tion could achieve sufficient endocardial hypothermia to create transmural lesions
leading to acute and sustained pulmonary vein isolation in a normothermic beating-
heart model.
Methods: Thirty-five– to 45-kg pigs underwent median sternotomy. Epicardial cryoa-
blation was performed on the right ventricle after insertion of thermocouples. Endo-
cardial temperatures from thermocouples were recorded continuously and correlated
with the thickness of the myocardium. Thirteen animals underwent pulmonary vein
isolation as a box lesion by using 5-minute epicardial cryoablation. Endocardial tem-
peratures were measured in 5 of these animals. Ten animals survived for 7 or 30 days.
Electrical isolation was tested at the time of surgical intervention and again at death.
Hearts were removed en bloc and submitted for gross and microscopic examination.
Results: Endocardial temperature varied inversely with tissue thickness, ranging from
260C in 5-mm-thick tissue to staying unchanged in tissue more than 10 mm thick.
During pulmonary vein isolation, median endocardial temperatures were between
21C and 222C. Acute electrical isolation was achieved in all 13 animals. All ex-
cept one of the animals maintained electrical isolation long-term. Histologic analysis
revealed transmurality in 89% of sections, although none of the box lesions were
completely transmural.
Conclusion: Epicardial cryoablation can produce long-term pulmonary vein isolation
in a beating heart. Dose-response studies demonstrate consistent endocardial hypo-
thermia in tissues up to 7 mm thick. To our knowledge, this is the first report docu-
menting endocardial hypothermia during epicardial cryoablation. This technology
holds promise for performing the complete maze procedure on a beating heart.
T
he development of the maze procedure was a major milestone in the field of
arrhythmia surgery.1 But despite its excellent results,1-3 it was never widely
adopted because of its complexity. To simplify the procedure, Cox and others
successfully replaced many of the cut-and-sew maze lesions with linear cryoabla-
tions.4,5 The success of the maze procedure depends on transmural replacement of
myocytes (which conduct electricity) by fibrocytes in the scar (which are effective in-
sulators). In this regard cryoablation was particularly attractive to the surgeon because
one could visualize the ice ball forming on the surface of the arrested heart, thus
ensuring transmurality.
Beating-heart epicardial cryoablation (EC) is, however, considered a poor model
for creating transmural lesions. There is a considerable body of evidence that shows
that the efficacy of EC is decreased when the cryoprobe is applied on a beating heart
with normal cardiac output.6-10 However, the size and depth of the cryolesion also de-
pends on a variety of other factors, including the temperature and size of the probe and
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the duration and number of the freeze/thaw cycles to which
the tissue is subjected.11-14 With a study design to optimize
the ablative potential of cryothermia, this study was con-
ducted to test the following hypotheses: (1) that EC can
achieve adequate endocardial hypothermia (for cell killing),
(2) that pulmonary vein isolation (PVI) can be performed
with EC, and (3) that EC is associated with histologically
transmural lesions.
Materials and Methods
Experimental Protocol
Thirteen Yorkshire pigs weighing 35 to 45 kg were used in this
study, 2 in the acute study and 11 in the chronic (long-term) study.
All animals received humane care in compliance with the ‘‘Guide
for the care and use of laboratory animals’’ (National Academy
Press, Washington, DC). After overnight fasting, each animal was
premedicated, intubated, anesthetized with 2% to 4% isoflurane,
and monitored continuously throughout the procedure. Except for
the first animal in the study, heparin was not used. No antiarrhyth-
mic agents were used during or after the procedure.
Cryoablation Device
Surgifrost XL (SFXL; CryoCath Technologies, Inc, Kirkland, Can-
ada) is a newer device similar to the original Surgifrost (SF6) device,
which uses argon gas as a refrigerant and is described in detail else-
where (Fig E1).15 It has a 26-cm malleable shaft followed by a 15-
cm flexible cryoprobe. The probe is covered by a fixed insulating
sheath around 270 degrees of circumference, leaving only 90 of
exposed surface for cryoablation. There is an additional circumfer-
ential mobile sheath that can be passed over the probe to change the
length of the ablating segment as needed.
Measurement of Endocardial Temperature
Chromel-constantan thermocouples (TCs; Fig E2) were used to re-
cord endocardial temperature. The data were acquired 100 times per
second, and the average was recorded once every second on a Daq-
book 260 (IOtech, Cleveland, Ohio) by using Daqview version 9.0.3
software (IOtech). The tip of the TC was attached to a 1- to 2-mm-
long steel wire at right angles. Each TC was mounted on a 21-gauge
needle, which was inserted into the heart. The needle was then with-
drawn, leaving the TC inside. The TCwas pulled up snug against the
endocardial surface—the horizontally oriented wire preventing it
from slipping out. Sufficient endocardial hypothermia was defined
as a temperature of at least23C to210C, which has been known
to be lethal to cells.16
In 2 acute animals TCs were inserted along a straight line in the
anterior wall of the right ventricle. Linear cryoablation was per-1328 The Journal of Thoracic and Cardiovascular Surgery c Juformed on the right ventricle over the TCs (Fig E3). At the end of
the experiment, the linear strip of cryoablated right ventricular myo-
cardium and the embedded TCs were excised. The thickness of the
myocardiumwas measured at each TC and recorded against the low-
est temperature recorded by that TC.
In 5 animals (2 acute and 3 long-term) TCs were inserted into the
left atrium at 2 locations after positioning the cryoprobe around the
pulmonary veins, as described below. One was placed on the infe-
rior left atrium (between the left inferior and right inferior pulmo-
nary veins) and another in the interatrial groove (between the right
superior and right inferior pulmonary veins). The TCs were inserted
from one side of the cryoprobe, aiming for a point on the endocar-
dium opposite the center of the cryoprobe.
Surgical Procedure
The heart was exposed through a median sternotomy, and the peri-
cardium was opened longitudinally. By using blunt dissection, the
transverse sinus was accessed between the superior vena cava and
the right superior pulmonary vein and the oblique sinus between
the inferior vena cava and the right inferior pulmonary vein. A red
rubber catheter was introduced from the right side into the transverse
sinus and returned through the oblique sinus, thus encircling all 4
pulmonary veins. The tip of the cryoprobe was secured in the distal
end of the red rubber catheter. As the rubber catheter was pulled out
of the oblique sinus, the probe took its place around the 4 pulmonary
veins (Fig E4). The right inferior pulmonary vein was paced at 120
beats/min, with stimulus strength of 1 mA at 50 ms. A 5-minute cry-
oablation was started simultaneous with pacing from the pulmonary
vein at 15 mA. Electrical isolation (EI) was defined as failure to pace
at 15 mA. Once EI was verified, the probe was thawed and removed.
The pacing wire was tunneled under the skin, the chest was closed,
and the animal was allowed to wake up.
Postoperative Care and Data Collection
The animals were closely monitored for 48 hours and survived for 7
or 30 days. For euthanasia, the animals were fasted overnight, pre-
medicated, intubated, and anesthetized. The heart was accessed
through the previous median sternotomy. The previously placed
pacing wire on the right pulmonary vein was used to check for
chronic EI. The animal was then killed, and the heart was removed
en bloc and fixed in 10% formalin.
Histologic and Microscopic Analysis
The hearts were examined for evidence of intra-atrial thrombus and
pulmonary vein stenosis. Two- to 4-mm-thick sections were cut,
starting from the center of the posterior left atrium and extending ra-
dially outward like the spokes of a bicycle wheel. Serial sections
were taken in a clockwise direction, thus sampling the entire circum-
ferential cryolesion. Sections were embedded in paraffin, and 2
slides from each section were stained with hematoxylin and eosin,
Masson trichrome, or both stains. Qualitative assessment was
performed for each slide.
Results
Tissue Thickness and Endocardial Hypothermia
During right ventricular EC, tissue thickness was directly re-
lated to endocardial temperature (Fig 1). The median lowest
endocardial temperature in 5- and 7-mm-thick tissue wasne 2008
Masroor et al Evolving TechnologyFigure 1. A scatter plot depicting the lowest tem-
peratures reached during epicardial cryoablation
of right ventricular myocardium of varying thick-
ness.ET260C and 25C (range, 218C to 285C and 20C to
252C), respectively. A typical dose-response curve is
shown in Fig 2. Tissues of 1 cm or larger remained normo-
thermic throughout. The temperature decrease was rapid
between 30 and 60 seconds and then plateaued at 150 to
180 seconds.
Endocardial Hypothermia During PVI
The median lowest endocardial temperature was 21C
(range, 1C to 238C) in the interatrial groove and 223C
(range, 214 to277C) in the inferior left atrium. A typical
recording of the endocardial temperature is shown in Fig 3.
Operative Results
PVI was performed successfully in all 13 animals (2 acute
and 11 chronic). All chronic animals were neurologically in-
tact after the procedure. The first animal in the long-termThe Journal of Thorstudy was extubated too early and died of respiratory failure
1 hour later.
Pulmonary Vein Isolation
PVI consisted of a box lesion, which was completed in most
animals as one circumferential lesion. In 4 of the 10 chronic
animals, a second EC was performed. In 2 animals there was
no EI after the first EC. In another 2 animals circumferential
positioning of the cryoprobe resulted in hemodynamic com-
promise. Therefore 3 sides of the box lesion were created
first from the transverse to the oblique sinus, followed by
a linear ablation in the interatrial groove, connecting the 2
ends of the first lesion. Acute EI was achieved within 90 to
150 seconds of the start of ablation in animals that required
only 1 ablation. In animals requiring 2 ablations, this hap-
pened within 90 to 150 seconds of the start of the second
ablation.Figure 2. A typical dose-response curve of
right ventricular endocardial temperature during
5-minute epicardial cryoablation.acic and Cardiovascular Surgery c Volume 135, Number 6 1329
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atrial endocardial temperature during 5-minute
epicardial cryoablation.Chronic EI
Of the 10 chronic animals, 2 died at euthanasia before confir-
mation of EI (1 was killed on day 3 because of massive gas-
trointestinal bleed, and the other was killed as per protocol on
day 30). They are, however, included in the histologic anal-
ysis. Seven (87.5%) of 8 animals demonstrated chronic EI.
The one animal that escaped EI had a large lymph node on
the roof of the left atrium in the ablation line.
Histology
Gross examination of the endocardial surface revealed the ab-
lation line as a patchy white line on the outer ostia of the pul-
monary veins. The endocardium was smooth and glistening.
Thickness varied from 4 to 5.1 mm, with maximum thickness
being in the right lateral part of the left atrium. A total of 108
sections were studied. Transmural fibrosis (Fig E5) was seen
in 96 (89%) sections, and midmural fibrosis was seen in the
remaining 12 sections. Moreover, each animal had at least
one nontransmural lesion. The width of the lesion on the
epicardial surface varied between 10 and 20 mm.
Discussion
The use of cryoablation in the treatment of cardiac arrhyth-
mias goes back to 1977,17,18 when it was first used endocar-
dially to ablate either aberrant atrioventricular conduction
pathways or the His bundle for disabling supraventricular
tachyarrhythmias. Successful EC was later reported, but
that was limited to relatively superficial atrioventricular path-
ways.7,8,19 In some cases of severe cardiac hypertrophy, cry-
oablation of the His bundle was not successful, even on full
cardiopulmonary bypass. Based on this and similar other ev-
idence, there is a general consensus in the scientific commu-1330 The Journal of Thoracic and Cardiovascular Surgery c Junity that EC cannot create transmural lesions in the left atrium
in a normothermic beating heart.
However, more recent work has shown that (1) liquid
nitrogen at 2150C to 2196C creates larger and deeper
lesions than nitrous oxide at 270C; (2) 5-minute ablations
create deeper lesions than 2-minute ablations, and the effect
of cryoablation plateaus at around 5 to 6minutes; (3) multiple
ablations can create a lesion larger than a single prolonged
ablation; (4) the cell damage is greater if a rapid freeze is fol-
lowed by a slow thaw; and (5) immediate cell killing is fol-
lowed by more cell death at the periphery of the cryolesion
by apoptosis, with this last effect being more pronounced
with a slower thawing process.10-13,20 We therefore hypothe-
sized that the ablative potential of cryothermia can be maxi-
mized by using a cooler cryoprobe (reaching 2130C),
longer ablations (5 minutes), repeat ablations as needed
(rather than 1 prolonged freeze), and a slower thaw (no
warm saline to hasten the process). Actual endocardial tem-
peratures were measured for the first time to see whether hy-
pothermia was severe enough to even expect transmurality.
Our results are encouraging.We have demonstrated a very
high degree of histologic transmurality, which correlates well
with chronic EI. But more importantly, not only was acute EI
achieved in all animals, it was also maintained long-term in
88% of them. The 1 animal that broke through EI at long-
term had a lymph node in the ablation line. The increased
thickness might have been responsible for the lack of long-
term EI. Although a midmural lesion was identified in that
animal, it cannot be reliably ascertained whether the midmu-
ral lesion was at the site of the lymph node.
These results are at odds with those of Doll and col-
leagues,15 who used a sheep model of EC with the SF6 de-
vice. In their report PVI was successful in 25% of animalsne 2008
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ETacutely and in 62.5% of animals after 2 hours. In thicker tis-
sues of the left and right atrial appendages, only 12% of an-
imals had EI. Transmurality rates were similarly poor, even
though the thickness of the left and right atrial appendages
was between 3.2 to 3.8 mm. No endocardial temperatures
were measured, and no animals survived long-term.
There are many reasons why there is such a discrepancy
between our results. SFXL is a stronger device, with an argon
flow rate of 100 L/min, as opposed to 60 L/min in SF6. Doll
and colleagues15 reported inconsistent probe temperatures of
between 298C to 2160C, resulting in a mean of about
2137C. With SFXL, probe temperatures were consistently
less than 2130 C in all animals. Another difference is the
fixed insulating sheath in SFXL, which allows cryoablation
to proceed predominantly along the exposed 90 of the probe,
thus preventing unnecessary loss of cooling power to adja-
cent tissues. Consistently lower temperatures might be a
reflection of better probe–tissue contact because of the
circumferential position of the probe, which tightened like
a noose around the 4 pulmonary veins during ablation.
Another difference is the duration and rate of cryoabla-
tion. Even though EI was seen earlier in our study, the tem-
perature did not reach a plateau until 150 to 180 seconds.
Holman and associates10 showed that in human cadaveric
hearts the size of the cryolesion continued to increase beyond
5 minutes. Therefore it is unlikely to have transmural lesions
when EC is performed for only 2 minutes. Snyder and
coworkers21 have recently reported that 95% of mammalian
cells lose their viability when exposed to temperatures of
less than 213C for 15 to 60 seconds. In the absence of en-
docardial temperature measurements, we can only speculate
that in the study by Doll and colleagues,15 the endocardial
cells were not receiving an adequate degree or duration of
hypothermia.
Another important factor is the rate of cooling.11 SFXL
might be causing a bigger cryolesion not just by cooling
more but also by cooling faster. In our experiments rapid
cooling happened in the first 30 to 60 seconds. SF6, beingThe Journal of Thoraa weaker device, might have a lower degree of transmurality
because of a slower rate of cooling.
Lastly, the effect of hypothermia can be enhanced by mul-
tiple freeze/thaw cycles. This is due to increased thermal con-
ductivity of tissues with repeated cryoablations. The reasons
for this are not clear, but they might be related to changes
in the cellular structure or the local microperfusion environ-
ment during thawing.11 The fact that they did not attempt
a second ablation might have hampered their ability to
achieve transmurality.
One of the reasons Cox used cryoablation was the fact that
he could visualize ‘‘transmurality’’ in the form of an ice
ball.19 Theoretically, at least, this might not necessarily be
true. The temperature at the edge of the cryolesion is likely
to be 20.6C, which is the freezing point of mammalian tis-
sue. That temperature is still not cold enough because the kill-
ing temperature of cells varies between 23C and 210C,
and it might even be lower for a cardiac myocyte.21 To our
knowledge, this is the first reported study in which actual
endocardial temperature was measured during EC.
The right ventricular myocardial temperatures were less
than the left atrial temperatures measured during PVI. The
reason for this is the way the temperatures were measured
in the 2 chambers. During right ventricular ablations, TCs
were placed first, followed by cryoablation immediately on
top of the TCs, ensuring the near-vertical spatial relationship
between the TC and the cryoprobe (Fig 4). During PVI, on
the other hand, the probe was positioned first because of
the risk of dislodgement of TCs during manipulation of the
cryoprobe. The TCs were introduced next from one side of
the probe, aiming for a spot on the endocardium exactly op-
posite the center of the probe. In a beating heart this position-
ing is not very exact. The TCs could have been a short
distance away from the actual tip of the hemispherical cryo-
lesion (Fig 4). The measured endocardial temperature of the
left atrium (between21C and222C) was likely not that of
the tip of the cryolesion, which would have been lower and
closer to the right ventricular temperatures.Figure 4. A cartoon depicting the possible position of the thermocouple in relation to the tip of the cryoprobe during
epicardial cryoablation of the right ventricle (A) versus the left atrium (B; see text). PVI, pulmonary vein isolation.cic and Cardiovascular Surgery c Volume 135, Number 6 1331
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cations is real. This is because there is no epicardial fat in the
inferior part of the left atrium, whereas the interatrial groove
has quite a lot of epicardial fat and nerve tissue. The left atrial
wall is also thicker in this area. The temperatures would have
been closer together had we dissected the interatrial groove
more, like during left atriotomy for mitral valve surgery.
These temperature measurements are important from an-
other standpoint. There is always the concern of the damage
to red blood cells because of cryoablation. Oeveren and asso-
ciates22 cryoablated blood at 270C for 60 seconds with
a cryocatheter in a closed-loop circuit of blood flowing at
3.5 to 6 mL/min. Calculating the amount of plasma hemoglo-
bin released, they concluded that a constant small amount of
blood cells in the ice ball around the probe (60 mL) was being
lysed. The remaining blood flowing around the probe was un-
affected. By using the same experiments with a radiofre-
quency catheter, a much larger degree of red cell and
platelet damage was seen. Moreover, macroparticles (with
a potential for embolism) were seen in circulating blood,
which were not seen with cryoablation. In our study the blood
is being cryoablated by the endocardial cryoablation line,
which can reach temperatures as low as 260C. However,
the cryolesion is a hemisphere of 10 to 20 mm in diameter
(the width of the epicardial lesion). Therefore the actual en-
docardial ablation line is much narrower than 10 mm. With
the pulmonary vein and mitral flow velocities in human sub-
jects being 20 to 100 cm/s in normal hearts and as low as 10
cm/s in dilated hearts in atrial fibrillation,23 the number of red
cells in contact with the endocardial ablation line at any given
time is very small. Damage will be limited to this very small
number of red cells and not those flowing past it and is
unlikely to be of any clinical significance.
In our study acute EI proved to be a valid procedural end
point. Not only was acute EI sustained chronically, it also
correlated well with transmurality. Interestingly, each animal
had at least 1 section that was nontransmural. The issue of
transmurality being a requirement for EI has been questioned
by others also.24,25 In a recent report, Accord and col-
leagues24 described 3 patients who had undergone successful
microwave ablation and had died of unrelated causes. Histo-
logic examination of their hearts revealed 3 of 13 sections be-
ing transmural, 7 were midmural, and 3 had no lesion at all.
They also reported a mean left atrial wall thickness of 4.3
mm, which falls within the range of thickness seen in our
study. Although the reasons for this finding are not the sub-
ject of this article, it might be that for energy sources that cre-
ate wide lesions, such as microwave and cryoablation, the
requirement for transmurality is not as stringent as it is for
bipolar radiofrequency ablation, which creates very thin
discrete lesions. It might also be that transmurality is
a surrogate for the ‘‘mass of ablated left atrial tissue’’: the
greater the transmurality, the greater the mass of ablated tis-
sue. The question then becomes whether there is a critical1332 The Journal of Thoracic and Cardiovascular Surgery c Jumass of atrial tissue that has to be ablated to prevent the
left atrium from being able to sustain macroreentrant circuits.
In conclusion, we have demonstrated the following using
the current technology: (1) it is possible to produce adequate
endocardial hypothermia in myocardium up to 5 to 7 mm
thick, and (2) long-term PVI is possible with beating-heart
EC. Its use in human subjects should be considered carefully.
Although the thickness of many human left atria will be
within this range,24 they can sometimes be much thicker,
such as in patients with mitral stenosis. Also, it is important
to test for EI, which can guide the surgeon if multiple abla-
tions are needed. This study has answered some questions
but also questioned some previously known answers, such
as the requirement of transmurality for EI. The results of
this study give us optimism that it might be possible to per-
form the complete maze operation by means of EC without
using cardiopulmonary bypass.
References
1. Cox JL, Boineau JP, Schuessler RB, Ferguson TB Jr, Cain ME,
Lindsay BD, et al. Successful surgical treatment of atrial fibrillation.
JAMA. 1991;266:1976-80.
2. Cox JL, Jaquiss RD, Schuessler RB, Boineau JP. Modification of the
maze procedure for atrial flutter and atrial fibrillation. II. Surgical tech-
nique of the maze II procedure. J Thorac Cardiovasc Surg. 1995;110:
485-95.
3. Prasad SM, Maniar HS, Camillo CJ, Schuessler RB, Boineau JP,
Sundt TM 3rd, et al. The Cox Maze III procedure for atrial fibrillation:
long-term efficacy in patients undergoing lone versus concomitant pro-
cedures. J Thorac Cardiovasc Surg. 2003;126:1822-8.
4. AdN, Cox JL. TheMaze procedure for the treatment of atrial fibrillation:
a minimally invasive approach. J Card Surg. 2004;19:196-200.
5. Nakajima H, Kobayashi J, Bando K, Niwaya K, Tagusari O, Sasako Y,
et al. The effect of cryo-maze procedure on early and intermediate term
outcome in mitral valve disease: a case matched study. Circulation.
2002;106(suppl 1):I46-50.
6. Guiraudon GM, Klein GJ, Sharma AD. Closed heart technique for
Wolff-Parkinson-White syndrome: further experience and potential
limitations. Ann Thorac Surg. 1986;42:651-7.
7. Holman WL, Masatoshi I, Douglas JM, Smith PK, Cox JL. Cardiac
cryosurgery: effects of myocardial temperature on cryolesion size.
Surgery. 1983;93:268-72.
8. Guiraudon GM, Klein GJ, Yee R, Kaushik R, McLellan DG, Cade DM.
Surgical epicardial ablation of left ventricular pathway using sling expo-
sure. Ann Thorac Surg. 1990;50:968-71.
9. Bredikis J, Bukauskas F, Zebrauska R, Sakalauskas J, Loschilov V,
Nevsky V, et al. Cryosurgical ablation of right parietal and septal acces-
sory atrioventricular connections without the use of extracorporeal circu-
lation. A new surgical technique. J Thorac Cardiovasc Surg. 1985;90:
206-11.
10. Holman WL, Kirklin JK, Anderson PG, Pacifico AD. Variation in cry-
olesion penetration due to probe size and tissue thermal conductivity.
Ann Thorac Surg. 1992;53:123-6.
11. Lustgarten DL, Keane D, Ruskin J. Cryothermal ablation: mechanism of
tissue injury and current experience in the treatment of tachyarrhyth-
mias. Prog Cardiovasc Dis. 1999;41:481-98.
12. Ghalili K, Roth JA, Kwan SK, Ferrick K, Fisher JD, Frame R, et al.
Comparison of left ventricular cryolesions created by liquid nitrogen
and nitrous oxide. J Am Coll Cardiol. 1992;20:1425-9.
13. Misaki T, Allwork SP, Bentall HH. Long-term effects of cryosurgery in
the sheep heart. Cardiovasc Res. 1983;17:61-9.
14. Watanabe S, Koyanagi H, Endo M, Yagi Y, Shiikawa A, Kasanuki H.
Cryosurgical ablation of accessory atrioventricular pathways without
cardiopulmonary bypass: an epicardial approach for Wolff-Parkinson
White syndrome. Ann Thorac Surg. 1989;47:257-64.ne 2008
Masroor et al Evolving Technology15. Doll N, Kornherr P, Aupperle H, Fabricius AM, Kiaii B, Ullmann C,
et al. Epicardial treatment of atrial fibrillation using cryoablation in an
acute off-pump sheepmodel. Thorac Cardiovasc Surg. 2003;51:267-73.
16. Mazur P. Cryobiology: the freezing of biological systems. Science.
1970;168:939-49.
17. Gallagher JJ, Sealy WC, Anderson RW, Kasell J, Millar R,
Campbell RW, et al. Cryosurgical ablation of accessory atrioventricular
connections; am method for correction of the pre-excitation syndrome.
Circulation. 1977;55:471-9.
18. Harrison L, Gallagher JJ, Kasell J, Anderson RW, Mikat E, Hackel DB,
et al. Cryosurgical ablation of the AV-node-His bundle: a new method
for producing A-V block. Circulation. 1977;55:463-70.
19. Cox JL. Intraoperative options for treating atrial fibrillation associated
with mitral valve disease. J Thorac Cardiovasc Surg. 2003;
125(suppl):S24-7.
20. Leibo SP, Farrant J, Mazur P, Hanna MG Jr, Smith LH. Effects of freez-
ing on marrow stem cell suspensions: interactions of cooling and warm-The Journal of Thoraing rates in the presence of PVP, sucrose, or glycerol. Cryobiology.
1970;6:315-32.
21. Snyder KK, Baust JM, Van Buskirk RG, Baust JG. Cardiomyocyte
responses to thermal excursions: implications for electrophysiological
cardiac mapping. Cell Preservation Technol. 2007;5:116-28.
22. Oeveren WN, Crijns HJGM, Korteling BJ, Wegereef EW, Haan J,
Tigchelaar I, et al. Blood damage, platelet and clotting activation during
application of radiofrequency or cryoablation catheters: a comparative in
vitro study. J Med Eng Technol. 1999;23:20-5.
23. Oh JK, Seward JM, Tajik AJ. Assessment of diastolic function and di-
astolic heart failure. In: Oh JK, Seward JM, Tajik AJ, eds. The echoman-
ual. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2006:120-42.
24. Accord RE, Van Suyden RJ, Van Brakel TJ, Maessen JC. Post-mortem
histologic evaluation of microwave lesions after epicardial pulmonary
vein isolation for atrial fibrillation. Ann Thorac Surg. 2005;80:881-7.
25. Smith JM, Hassan M, Ignacio R. Robot-assisted isolation of the pulmo-
nary veins using microwave energy. J Card Surg. 2006;21:83-8.ETcic and Cardiovascular Surgery c Volume 135, Number 6 1333
Evolving Technology Masroor et al
ETFigure E1. A, Surgifrost XL probe. B, Close-up view of the ablating
segment with a fixed sheath covering the outer 270 circumference.1333.e1 The Journal of Thoracic and Cardiovascular Surgery c June 2008
Masroor et al Evolving TechnologyFigure E2. Chromel-constantan thermocouple attached to a horizon-
tally oriented steel wire, which prevents it from slipping out of the
heart.The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 6 1333.e2
ET
Evolving Technology Masroor et al
ETFigure E3. Linear cryoablation over the right ventricle. Thermo-
couples are seen exiting under the cryoprobe.1333.e3 The Journal of Thoracic and Cardiovascular Surgery c June 2008
Masroor et al Evolving TechnologyFigure E4. Epicardial cryoablation in progress with the Surgifrost
XL probe tightened around all 4 pulmonary veins.The Journal of Thoracic and Cardiovascular Surgery c Volume 135, Number 6 1333.e4
ET
Evolving Technology Masroor et al
ETFigure E5. Masson trichrome staining showing a transmural
lesion.1333.e5 The Journal of Thoracic and Cardiovascular Surgery c June 2008
